OBJECTIVE: The Hopelessness Theory of Depression provides the framework to test feelings of hopelessness and social support as predictors of depressive symptoms in women recently diagnosed with a recurrence of breast cancer. METHODS: Patients (N=67) were assessed within weeks of receiving their recurrence diagnosis (initial) and again 4 months later (follow-up). RESULTS: Controlling for their current physical and depressive symptoms, hopelessness at diagnosis was a significant predictor of the maintenance of depressive symptoms among patients. A corollary of the theory was also confirmed: social support (i.e. the presence/absence of a romantic partner) interacted with hopelessness. CONCLUSIONS: Women who reported feelings of hopelessness and who were alone (i.e. without a partner) were especially vulnerable to later depressive symptoms. The data provide support for the Hopelessness Theory and suggest factors conferring risk for depressive symptoms for those coping with a worsened cancer prognosis.
OBJECTIVE: The Hopelessness Theory of Depression provides the framework to test feelings of hopelessness and social support as predictors of depressive symptoms in women recently diagnosed with a recurrence of breast cancer. METHODS:Patients (N=67) were assessed within weeks of receiving their recurrence diagnosis (initial) and again 4 months later (follow-up). RESULTS: Controlling for their current physical and depressive symptoms, hopelessness at diagnosis was a significant predictor of the maintenance of depressive symptoms among patients. A corollary of the theory was also confirmed: social support (i.e. the presence/absence of a romantic partner) interacted with hopelessness. CONCLUSIONS:Women who reported feelings of hopelessness and who were alone (i.e. without a partner) were especially vulnerable to later depressive symptoms. The data provide support for the Hopelessness Theory and suggest factors conferring risk for depressive symptoms for those coping with a worsened cancer prognosis.
Authors: Barbara L Andersen; Charles L Shapiro; William B Farrar; Timothy Crespin; Sharla Wells-Digregorio Journal: Cancer Date: 2005-10-01 Impact factor: 6.860
Authors: Chiara Nosarti; Jonathan V Roberts; Timothy Crayford; Kwame McKenzie; Anthony S David Journal: J Psychosom Res Date: 2002-12 Impact factor: 3.006
Authors: Wayne A Bardwell; Loki Natarajan; Joel E Dimsdale; Cheryl L Rock; Joanne E Mortimer; Kathy Hollenbach; John P Pierce Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544
Authors: Lisa M Thornton; Anna O Levin; Caroline S Dorfman; Neha Godiwala; Carolyn Heitzmann; Barbara L Andersen Journal: Psychooncology Date: 2013-10-14 Impact factor: 3.894
Authors: Kelly Yu-Hsin Liao; Nelson C Y Yeung; Celia C Y Wong; Krystal Warmoth; Qian Lu Journal: Support Care Cancer Date: 2016-12-06 Impact factor: 3.603
Authors: Katherine N DuHamel; Catherine E Mosher; Gary Winkel; Larissa E Labay; Christine Rini; Yeraz Markarian Meschian; Jane Austin; Paul B Greene; Catalina R Lawsin; Anna Rusiewicz; Celia L Grosskreutz; Luis Isola; Craig H Moskowitz; Esperanza B Papadopoulos; Scott Rowley; Eileen Scigliano; Jack E Burkhalter; Karen E Hurley; Andreas R Bollinger; William H Redd Journal: J Clin Oncol Date: 2010-07-12 Impact factor: 44.544
Authors: Lisa M Thornton; Jennifer S Cheavens; Carolyn A Heitzmann; Caroline S Dorfman; Salene M Wu; Barbara L Andersen Journal: J Consult Clin Psychol Date: 2014-06-02